Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Diagnostica Stago Acquires Dutch Thrombin Generation Company

By LabMedica International staff writers
Posted on 20 Oct 2010
Diagnostica Stago, Inc. More...
(DSI; Parsippany, NJ, USA), finalized the acquisition of Thrombinoscope, BV (Maastricht, The Netherlands). Originally developed at Maastricht University, Thrombinoscope, researches, develops, and markets thrombin generation (TG) systems through the use of the Calibrated Automated Thrombogram (CAT) system. The CAT system is available for research-only use.

"The development potential of this new TG approach in hemostasis using the CAT system is very promising," noted Stephane Zamia, Ph.D., and CEO of DSI. "The addition of this approach to Stago's portfolio will allow our customers to measure TG in real-time and in larger, scalable studies."

Operations and research at the company will remain independent within the Stago Group, and will report directly to the company's scientific and clinical department. The Stago Group believes that by remaining independently controlled, this start-up company will continue promising creativity leading to product development, citing their recent acquisition of BioCytex (Marseille, France), a company specializing in standardized kits for flow cytometric analysis of blood cells.

TG is a universal test capable of assessing a patient's global hemostatic balance in the instance of hemorrhage or thrombosis. Few methods before this had allowed for TG standardization and calibration. Thrombinoscope introduced a patented, sample-specific calibrator that allows for error correction due to inter-subject plasma composition and color variations, as well as substrate consumption. This method is both specific and sensitive, thereby giving increased relevance to this hemostatic test in academic research centers, pharmaceutical companies, and contract research organizations.

Diagnostica Stago, Inc. is the exclusive provider of the Diagnostica Stago Hemostasis product lines in the United States and offers a complete system of coagulation instruments and optimized reagent kits for research as well as for routine analysis. Diagnostica Stago, Inc. is the U.S. subsidiary of Diagnostica Stago, S.A.S. France (Asnières sur Seine, France), a developer and manufacturer of Hemostasis products.

Related Links:

Diagnostica Stago
Thrombinoscope





New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.